Top 15 Companies in Global Lateral Flow Assays 2025: Market Intelligence and Investment Trends (2024–2035)

Description

According to a research report published by Spherical Insights & Consulting, The Global Lateral Flow Assays Market Size Is Projected To Grow From USD 2.59 Billion In 2024 To USD 6.32 Billion By 2035, At A CAGR Of 8.45% During The Forecast Period 2024–2035.  The global lateral flow assays market is growing due to rising demand for rapid diagnostic testing, technological advancements in assay sensitivity, increasing adoption in point-of-care applications, and supportive regulatory frameworks, which are increasing adoption across multiple industries and supporting overall market expansion.

 

Introduction

The global lateral flow assays market comprises rapid diagnostic tests that detect the presence or absence of target analytes in clinical samples using immunochromatographic technology. The test strips, membranes, antibodies and detection labels of these assays create a system that enables quick testing at medical facilities. Healthcare professionals utilize lateral flow assays to detect infectious diseases and perform pregnancy tests, conduct veterinary diagnostics and assess environmental conditions. The market expansion results from the increasing demand for diagnostic solutions that can deliver fast and accurate results in decentralized testing environments. Recent developments introduce multiplex testing and smartphone-integrated readers and nanomaterial-based detection, which improves sensitivity. Hospitals, clinics and field settings establish point-of-care diagnostics as their primary diagnostic method because regulatory frameworks for these systems provide support for their implementation. The healthcare systems in all countries require portable diagnostic platforms that are affordable and easy to use for future applications in chronic disease monitoring, food safety assessment, and detection of emerging infectious diseases.

 

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the global lateral flow assays market.

 

Segment Insights: Key Segments Shaping Market Growth

Global Lateral Flow Assays Market Size, Share, By Product (Kits & Reagents, Lateral Flow Readers), By Application (Clinical Testing, Veterinary Diagnostics, Food Safety & Environment Testing, Drug Development & Quality Testing), By Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), By End-Use (Hospitals & Clinics, Diagnostic Laboratories, Home Care, Pharmaceutical & Biotechnology Companies, Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035

 

Global Lateral Flow Assays Market Size & Statistics

• The Market Size for Global Lateral Flow Assays Was Estimated to be worth USD 2.59 Billion in 2024.
• The Market is Going to Expand at a CAGR of 8.45% between 2024 and 2035.
• The Global Lateral Flow Assays Market Size is anticipated to reach USD 6.32 Billion by 2035.
• North America is expected to generate the largest demand during the forecast period in the Global Lateral Flow Assays Market
• Asia Pacific is expected to grow the fastest during the forecast period in the Global Lateral Flow Assays Market.

Regional growth and demand                                  

Asia Pacific is expected to grow the fastest during the forecast period in the global lateral flow assays market. Asia Pacific’s growth is driven by increasing demand for point-of-care diagnostics, rising prevalence of infectious diseases, and expanding veterinary and food safety testing programs. Government healthcare initiatives, including rapid testing campaigns, are accelerating adoption. Investments in multiplex detection assays, portable lateral flow readers, and advanced reagents are enhancing testing efficiency and accuracy. Growing local manufacturing capabilities are reducing costs and improving access, creating substantial opportunities for both regional and global diagnostic companies.

 

North America is expected to generate the largest demand during the forecast period in the global lateral flow assays market. The global lateral flow assays market dominance is supported by well-established healthcare infrastructure, widespread adoption of clinical and home-based rapid testing, and continuous innovation in lateral flow technology. Strong R&D activities, regulatory support for point-of-care diagnostics, and high hospital and laboratory penetration drive consistent market growth. Major players such as Abbott, Quidel, and BD contribute to advanced assay development, improved sensitivity, and expanded clinical applications.

 

 

Top 10 Trends in the Global Lateral Flow Assays Market

• Rising adoption of point-of-care diagnostics
• Expansion of multiplex detection assays
• Integration of digital and smartphone-based lateral flow readers 
• Growing use in infectious disease surveillance
• Increasing deployment in veterinary diagnostics
• Development of highly sensitive and rapid assay reagents
• Expansion in food safety and environmental testing applications
• Rising demand for home-based testing kits
• Adoption of automated and high-throughput lateral flow platforms
• Focus on cost-effective and portable testing solutions

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the global lateral flow assays market.

 

• Rising adoption of point-of-care diagnostics

The increasing adoption of point-of-care diagnostics is driving the global lateral flow assays market by enabling rapid, on-site testing for clinical, veterinary, and home care applications. This trend improves diagnostic speed, patient convenience, and operational efficiency across healthcare settings.

 

• Expansion of multiplex detection assays

The development of multiplex detection assays is enhancing the lateral flow assays market by allowing simultaneous detection of multiple biomarkers. This improves diagnostic accuracy, reduces testing time, and supports more comprehensive disease monitoring in clinical and research applications.

 

• Integration of digital and smartphone-based lateral flow readers

The integration of digital and smartphone-enabled readers is advancing the lateral flow assays market by providing real-time data capture, remote monitoring, and enhanced result interpretation. This innovation strengthens connectivity, accessibility, and scalability in testing programs.

 

• Growing use in infectious disease surveillance

Increasing deployment of lateral flow assays for infectious disease surveillance is improving epidemiological tracking and outbreak management. This trend enhances public health responsiveness, timely intervention, and broader population-level monitoring.

 

• Increasing deployment in veterinary diagnostics

The expanding use of lateral flow assays in veterinary diagnostics is supporting livestock health and food safety. This trend ensures rapid disease detection, biosecurity, and operational efficiency in agricultural and animal care sectors.

 

Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the global lateral flow assays market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

• Abbott Laboratories

Headquarters: Abbott Park, Illinois, USA

Abbott Laboratories is a global healthcare company actively engaged in the global lateral flow assays market, providing rapid diagnostic solutions for infectious diseases, cardiac, and consumer health testing. The company’s BinaxNOW platform and immunoassay technologies enable quick, accurate results. Abbott drives innovation through digital-read capabilities and portable testing formats, enhancing accessibility, efficiency, and reliability in point-of-care diagnostics worldwide.

 

• QuidelOrtho Corporation

Headquarters: San Diego, California, USA

QuidelOrtho Corporation specializes in rapid diagnostic testing solutions within the global lateral flow assays market. The company delivers immunoassay-based LFAs for infectious diseases and clinical diagnostics, emphasizing speed and accuracy. QuidelOrtho supports market growth by developing point-of-care innovations that simplify testing processes and enhance diagnostic efficiency in healthcare settings globally.

 

• Siemens Healthineers AG

Headquarters: Erlangen, Germany

Siemens Healthineers AG is a global medical technology leader contributing to the global lateral flow assays market through innovative diagnostic platforms and immunoassay solutions. The company integrates automation and digital-read technologies to improve test accuracy and workflow efficiency, supporting rapid diagnostics and advancing the availability of reliable, scalable testing solutions across clinical and point-of-care settings.

 

Are you ready to discover more about the global lateral flow assays market?

The report provides an in-depth analysis of the leading companies operating in the global lateral flow assays market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the global lateral flow assays market.

 

Company Profiles

• Business Overview
• • Company Snapshot
• • Products Overview
• • Company Market Share Analysis
• • Company Coverage Portfolio
• • Financial Analysis
• • Recent Developments
• • Mergers & Acquisitions
• • SWOT Analysis

 

Conclusion

The global lateral flow assays market is poised for significant growth, driven by rising demand for rapid, point-of-care diagnostics, technological advancements in assay sensitivity, and supportive regulatory frameworks. North America leads the market due to advanced healthcare infrastructure and high adoption of rapid testing, while Asia Pacific is the fastest-growing region, fueled by infectious disease prevalence, veterinary and food safety programs, and expanding local manufacturing. Leading companies such as Abbott, Roche, Danaher, QuidelOrtho, and Siemens Healthineers continue to innovate, enhancing efficiency, accuracy, and accessibility, and shaping the future of decentralized diagnostics worldwide.

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter